Fournier's Gangrene: A Review and Outcome Comparison from 2009 to 2016 | Canada Hyperbarics Skip to main content
Cohort Study Adv Wound Care (New Rochelle) 2017

Fournier's Gangrene: A Review and Outcome Comparison from 2009 to 2016

Ferretti M, Saji A, Phillips J — Adv Wound Care (New Rochelle), 2017

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers looked back at medical records of 20 patients with Fournier's gangrene at their institution between 2009 and 2016 to evaluate how different treatments affected their hospital stay and survival rates.

What They Found

The overall mortality rate was 15%, a significant decline from historical rates of 50-60%. Patients treated with hyperbaric oxygen therapy had an average hospital stay of 22 days, compared to 40 days for those treated with tangential hydrosurgery, and an overall average of 32 days. An increased Fournier's Gangrene Severity Index Score (FGSIS) predicted a higher mortality rate or a hospital stay longer than 25 days.

What This Means for Canadian Patients

This study suggests that hyperbaric oxygen therapy may be associated with shorter hospital stays for patients suffering from Fournier's gangrene. For Canadian patients facing this severe and rapidly progressing infection, treatments that can reduce hospital time could potentially improve recovery and lessen the burden on healthcare resources.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This study was limited by its small sample size of 20 patients and being a retrospective review from a single institution, which may not represent all patient experiences.

Was this summary helpful?

Study Details

Study Type Cohort Study
Category Infection
Source Pubmed
PubMed ID 28894636
Year Published 2017
Journal Adv Wound Care (New Rochelle)

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.